Has George Padkowsky, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,473 in general payments to George Padkowsky, MD across 89 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean George Padkowsky, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about George Padkowsky, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

George Padkowsky, MD

Internal Medicine · Bayonne, NJNPI 1497863864

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 34.2% of the total. Reporting peaked in 2021 at $477 and has fallen 89.7% since, to $49 in 2025.

$1,473in general payments, 2019–2025

Across 89 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$505
GSK$219
Novo Nordisk$179
Stryker$130
Bausch Health US, LLC$64
Biotronik NRO, Inc.$49
plus $328 from 15 others

What the payments were for

Food & beverage$1,473100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	33	$505
GSK	14	$219
Novo Nordisk	12	$179
Stryker	2	$130
Bausch Health US, LLC	5	$64
Biotronik NRO, Inc.	2	$49
Ultragenyx Pharmaceutical Inc.	2	$40
Vanda Pharmaceuticals Inc.	3	$39
Mylan Specialty L.p.	2	$36
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$30
Nevro Corp.	1	$30
Novartis	2	$26
Arbor Pharmaceuticals, Inc.	1	$17
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$16
Genentech USA, Inc.	1	$15
Boehringer Ingelheim	1	$15
Johnson & Johnson	1	$15
Lilly USA, LLC	1	$13
Currax Pharmaceuticals LLC	1	$13
Merck	1	$12
Aytu Biopharma, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TREVO$105

How this compares

$1,473 in reported general payments places this provider in the 70th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$30,550

Medicare patients

155

Services billed

346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	29	$31,103
Icosapent Ethyl	14	$2,868
Albuterol Sulfate HfaAlbuterol Sulfate	17	$667
Metoprolol Succinate	56	$612
Atorvastatin Calcium	48	$542
Pantoprazole Sodium	57	$482
Lisinopril	54	$408
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide	49	$396
Amlodipine Besylate	66	$347
Alprazolam	98	$335
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	17	$301
Tamsulosin Hcl	14	$299
Ketoconazole	16	$298
Diclofenac Sodium	27	$269
Fluticasone Propionate	13	$215

Paid to pharmacies, not to this prescriber.

Other internal medicine in Bayonne

David ShulkinMorristown$1.7M
Howard UdermanLakewood$955K
Darshi SunderamEast Orange$530K
Annika DrongeEmerson$401K
Stephen MarcellaNew Brunswick$331K
Viju VijaysadanKinnelon$325K
Mark MonaneWoodcliff Lake$268K
Martin BedigianLivingston$240K
Rameck HuntPlainsboro$217K
Angel LazoSecaucus$195K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →